Riskpilot← Back to searchSign inGet full accessKlaria Pharma Holding AB (publ)
ABActiveOrg 5569592917Virdings Allé 2Research and experimental development on natural sciences and engineering · NACE 7210Est. 20142 employees
Revenue 2024
SEK 4,9M
0% vs 2023
EBITDA margin
-105.8%
+39% vs 2023
Equity ratio
61.3%
Financial strength
Net profit 2024
SEK -80,6M
-223% vs 2023
| Revenue | SEK 4,9M | +0% |
| EBITDA | SEK -5,2M | +39% |
| Net profit | SEK -80,6M | -223% |
| Total assets | SEK 131,6M | -31% |
| Equity | SEK 80,6M | -47% |
| Employees | 2 | — |
Legal name
Klaria Pharma Holding AB (publ)
Org number
5569592917
Legal form
Aktiebolag
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
22 januari 2014
Share capital
SEK 2 413 000
Employees
2 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas två i förening av ledamöterna Dessutom har verkställande direktören rätt att teckna firman beträffande löpande förvaltningsåtgärder
Company purpose
Bolaget skall, direkt eller genom hel- eller delägda bolag, bedriva forskning och utveckling inom det medicinska området, marknadsföra och försälja medicinska tjänster och produkter ävensom idka annan därmed förenlig verksamhet.
Address
Virdings Allé 2
Email
info@klaria.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 4 953 | 4 897 | 4 990 | 4 902 | 4 922 |
| Staff expenses | — | — | — | — | — |
| EBITDA | −9 753 | −24 610 | −13 712 | −8 600 | −5 207 |
| Depreciation & amort. | — | — | — | — | — |
| EBIT | −9 753 | −24 610 | −13 712 | −8 600 | −5 207 |
| Net financials | −2 645 | −3 200 | −8 043 | −3 865 | −64 429 |
| Profit before tax | −36 481 | −43 095 | −53 575 | −24 922 | −80 572 |
| Tax | −0 | −0 | −0 | −0 | −0 |
| Net profit | −36 481 | −43 095 | −53 575 | −24 922 | −80 572 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 206 259 | 194 337 | 223 899 | 190 107 | 131 564 |
| Equity | 188 150 | 158 393 | 175 257 | 151 212 | 80 622 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 18 109 | 35 944 | 48 642 | 38 895 | 50 942 |
| Total debt | 18 109 | 35 944 | 48 642 | 38 895 | 50 942 |
EBITDA margin
-105.8%
This company
15.8%
Market median
-770% vs market
20202024
Equity ratio
61.3%
This company
38.2%
Market median
+60% vs market
20202024
Return on equity
-99.9%
This company
18.4%
Market median
-643% vs market
20202024
Net profit margin
-1637.0%
This company
8.1%
Market median
-20310% vs market
20202024
Asset turnover
0.04×
This company
1.12×
Market median
-96% vs market
20202024
Debt / equity
0.63×
This company
0.62×
Market median
+2% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
PG Chief Auditor | Chief Auditor | 2026 |
CS Chief Executive Officer | Chief Executive Officer | 2023 |
| Former (2) | ||
JP Chief Executive Officer | Chief Executive Officer | 2020 – 2023 |
EN Chief Auditor | Chief Auditor | 2020 – 2026 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Chairman | 2022 | |
| Board of Directors | 2020 | |
| Former (2) | ||
| Board of Directors | 2020 – 2022 | |
| Chairman | 2020 – 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Klaria Pharma Holding AB (publ) (this company)
Wbc Drug Delivery Technologies Gmbh Ag MunichWBC DRUG DELIVERY TECHNOLOGIES GMBH AG MUNICHBoard members of Klaria Pharma Holding AB (publ) also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Per Gustaf Hammar | Chief Auditor | 0 companies |
| Jesper Paul Fredrik Wiklund | Chief Executive Officer | 0 companies |
| Charles Scott Boyer | Chief Executive Officer | 0 companies |
| Eric Niklas Nordström | Chief Auditor | 0 companies |
| Claes Fredrik Hübinette | Chairman | 0 companies |
| Anders Daniel Ardstål | Board of Directors | 0 companies |
| Björn Littorin | Chairman | 0 companies |
| Anders Bertil Jakobson | Board of Directors | 0 companies |